BGMSP
BGMSP
Bio Green Med Solution, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $1.32M ▼ | $-1.32M ▼ | 0% | $0 | $-1.32M ▲ |
| Q1-2025 | $0 | $5.04M ▲ | $-81K ▲ | 0% | $0 | $-5.04M ▼ |
| Q4-2024 | $0 ▼ | $1.83M ▼ | $-3.05M ▼ | 0% ▲ | $0 | $-1.89M ▲ |
| Q3-2024 | $10K ▲ | $2.19M ▼ | $-1.96M ▲ | -19.57K% ▲ | $0 | $-2.18M ▲ |
| Q2-2024 | $4K | $3.65M | $-3.26M | -81.42K% | $0 | $-3.64M |
What's going well?
The company has made big cuts to its spending, especially in R&D and overhead. This shows management is trying to control losses and conserve cash.
What's concerning?
There is still no revenue at all, and the company is burning cash every quarter. Losses are growing again after a one-off boost last quarter, raising questions about long-term survival.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $4.28M ▲ | $4.4M ▲ | $770K ▲ | $3.63M ▲ |
| Q1-2025 | $3.45M ▲ | $3.73M ▼ | $672K ▼ | $3.06M ▲ |
| Q4-2024 | $3.14M ▲ | $4.09M ▼ | $6.27M ▼ | $-2.17M ▼ |
| Q3-2024 | $2.98M ▼ | $5.38M ▼ | $6.35M ▼ | $-970K ▼ |
| Q2-2024 | $6M | $8.19M | $7.19M | $999K |
What's financially strong about this company?
BGMSP has a huge cash cushion, almost no debt, and most assets are liquid. The company can easily cover all its bills and has a very safe financial position.
What are the financial risks or weaknesses?
Retained earnings are deeply negative, showing a long history of losses. Payables are rising, and the company may be relying on past capital raises rather than profits.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.32M ▼ | $-1.06M ▲ | $0 | $1.88M ▼ | $825K ▲ | $-1.06M ▲ |
| Q1-2025 | $-81K ▲ | $-3.25M ▼ | $0 | $3.65M ▲ | $313K ▲ | $-3.25M ▼ |
| Q4-2024 | $-3.05M ▼ | $-1.36M ▲ | $0 | $1.61M ▲ | $155K ▲ | $-1.36M ▲ |
| Q3-2024 | $-1.96M ▲ | $-3.07M ▲ | $0 | $-1K ▼ | $-3.02M ▼ | $-3.07M ▲ |
| Q2-2024 | $-3.26M | $-3.08M | $0 | $6.29M | $3.2M | $-3.08M |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, and the company managed to raise more cash than it spent, increasing its cash balance this quarter.
What are the cash flow concerns?
The business is not generating cash from operations, depends on selling stock to survive, and working capital is draining cash quickly. Without new funding, cash could run out in a few months.
About Bio Green Med Solution, Inc.
https://www.bgmsglobal.comBio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $1.32M ▼ | $-1.32M ▼ | 0% | $0 | $-1.32M ▲ |
| Q1-2025 | $0 | $5.04M ▲ | $-81K ▲ | 0% | $0 | $-5.04M ▼ |
| Q4-2024 | $0 ▼ | $1.83M ▼ | $-3.05M ▼ | 0% ▲ | $0 | $-1.89M ▲ |
| Q3-2024 | $10K ▲ | $2.19M ▼ | $-1.96M ▲ | -19.57K% ▲ | $0 | $-2.18M ▲ |
| Q2-2024 | $4K | $3.65M | $-3.26M | -81.42K% | $0 | $-3.64M |
What's going well?
The company has made big cuts to its spending, especially in R&D and overhead. This shows management is trying to control losses and conserve cash.
What's concerning?
There is still no revenue at all, and the company is burning cash every quarter. Losses are growing again after a one-off boost last quarter, raising questions about long-term survival.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $4.28M ▲ | $4.4M ▲ | $770K ▲ | $3.63M ▲ |
| Q1-2025 | $3.45M ▲ | $3.73M ▼ | $672K ▼ | $3.06M ▲ |
| Q4-2024 | $3.14M ▲ | $4.09M ▼ | $6.27M ▼ | $-2.17M ▼ |
| Q3-2024 | $2.98M ▼ | $5.38M ▼ | $6.35M ▼ | $-970K ▼ |
| Q2-2024 | $6M | $8.19M | $7.19M | $999K |
What's financially strong about this company?
BGMSP has a huge cash cushion, almost no debt, and most assets are liquid. The company can easily cover all its bills and has a very safe financial position.
What are the financial risks or weaknesses?
Retained earnings are deeply negative, showing a long history of losses. Payables are rising, and the company may be relying on past capital raises rather than profits.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.32M ▼ | $-1.06M ▲ | $0 | $1.88M ▼ | $825K ▲ | $-1.06M ▲ |
| Q1-2025 | $-81K ▲ | $-3.25M ▼ | $0 | $3.65M ▲ | $313K ▲ | $-3.25M ▼ |
| Q4-2024 | $-3.05M ▼ | $-1.36M ▲ | $0 | $1.61M ▲ | $155K ▲ | $-1.36M ▲ |
| Q3-2024 | $-1.96M ▲ | $-3.07M ▲ | $0 | $-1K ▼ | $-3.02M ▼ | $-3.07M ▲ |
| Q2-2024 | $-3.26M | $-3.08M | $0 | $6.29M | $3.2M | $-3.08M |
What's strong about this company's cash flow?
Cash burn is shrinking quarter over quarter, and the company managed to raise more cash than it spent, increasing its cash balance this quarter.
What are the cash flow concerns?
The business is not generating cash from operations, depends on selling stock to survive, and working capital is draining cash quickly. Without new funding, cash could run out in a few months.
CEO
Sing Ee Wong
Compensation Summary
(Year )
Upcoming Earnings
Ratings Snapshot
Rating : C-